Weight & Obesity

Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity and diabetes drug, the company announced March 24.This article was originally published […]

Motion sickness is a very common condition that affects about one in three people, but the brain circuits involved are largely unknown.This article was originally published on MedicalXpress.com

Obesity is linked to numerous health complications, including diabetes, cardiovascular disease, and fatty liver disease. In a world where obesity rates continue to climb, researchers are constantly seeking effective, accessible solutions to this global health […]

Researchers have developed a smartphone app that uses machine learning to accurately determine body composition—which is linked to a higher risk of heart disease, stroke and related conditions—from photographs.This article was originally published on MedicalXpress.com

Excess weight in midlife is a known risk factor for kidney cancer, but new research indicates that weight patterns throughout life may also affect an individual’s likelihood of developing this malignancy. The findings are published […]

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss. Unfortunately, shortages and high costs have made it difficult for people to start and maintain treatment.This article was originally published […]

New research to be presented at this year’s European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that a new diagnosis of type 2 diabetes is linked to a subsequent increase in the […]

Body size and excess weight, conventionally assessed using body mass index (BMI), are well-established risk factors for many types of cancer. However, new research to be presented at this year’s European Congress on Obesity (ECO […]

New research to be presented at this year’s European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that having an overweight or obese trajectory during childhood is associated with an increased risk of […]

In a study in the journal Diabetes Technology & Therapeutics (DTT), investigators evaluated biomarkers for cardiovascular disease (CVD) and diabetic kidney disease (DKD) in overweight and obese (OW/OB) adults with type 1 diabetes treated with […]